Literature DB >> 30281975

Cryo-EM Visualization of an Active High Open Probability CFTR Anion Channel.

Jonathan F Fay1, Luba A Aleksandrov1, Timothy J Jensen1, Liying L Cui1, Joseph N Kousouros1, Lihua He1, Andrei A Aleksandrov1, Drew S Gingerich2, John R Riordan1, James Z Chen2.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) anion channel, crucial to epithelial salt and water homeostasis, and defective due to mutations in its gene in patients with cystic fibrosis, is a unique member of the large family of ATP-binding cassette transport proteins. Regulation of CFTR channel activity is stringently controlled by phosphorylation and nucleotide binding. Structural changes that underlie transitions between active and inactive functional states are not yet fully understood. Indeed the first 3D structures of dephosphorylated, ATP-free, and phosphorylated ATP-bound states were only recently reported. Here we have determined the structure of inactive and active states of a thermally stabilized CFTR, the latter with a very high channel open probability, confirmed after reconstitution into proteoliposomes. These structures, obtained at nominal resolution of 4.3 and 6.6 Å, reveal a unique repositioning of the transmembrane helices and regulatory domain density that provide insights into the structural transition between active and inactive functional states of CFTR. Moreover, we observe an extracellular vestibule that may provide anion access to the pore due to the conformation of transmembrane helices 7 and 8 that differs from the previous orthologue CFTR structures. In conclusion, our work contributes detailed structural information on an active, open state of the CFTR anion channel.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30281975     DOI: 10.1021/acs.biochem.8b00763

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

Review 1.  Molecular mechanisms of cystic fibrosis - how mutations lead to misfunction and guide therapy.

Authors:  Carlos M Farinha; Isabelle Callebaut
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 2.  One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Authors:  Marjolein M Ensinck; Marianne S Carlon
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

3.  G551D mutation impairs PKA-dependent activation of CFTR channel that can be restored by novel GOF mutations.

Authors:  Wei Wang; Lianwu Fu; Zhiyong Liu; Hui Wen; Andras Rab; Jeong S Hong; Kevin L Kirk; Steven M Rowe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-02       Impact factor: 5.464

Review 4.  Pharmacological chaperones of ATP-sensitive potassium channels: Mechanistic insight from cryoEM structures.

Authors:  Gregory M Martin; Min Woo Sung; Show-Ling Shyng
Journal:  Mol Cell Endocrinol       Date:  2019-12-09       Impact factor: 4.102

5.  Structure of Ycf1p reveals the transmembrane domain TMD0 and the regulatory region of ABCC transporters.

Authors:  Sarah C Bickers; Samir Benlekbir; John L Rubinstein; Voula Kanelis
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

Review 6.  Multidrug Resistance in Mammals and Fungi-From MDR to PDR: A Rocky Road from Atomic Structures to Transport Mechanisms.

Authors:  Narakorn Khunweeraphong; Karl Kuchler
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

7.  Quantitative comparison of ABC membrane protein type I exporter structures in a standardized way.

Authors:  Georgina Csizmadia; Bianka Farkas; Zoltán Spagina; Hedvig Tordai; Tamás Hegedűs
Journal:  Comput Struct Biotechnol J       Date:  2018-10-18       Impact factor: 7.271

Review 8.  Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.

Authors:  Samuel Estabrooks; Jeffrey L Brodsky
Journal:  Int J Mol Sci       Date:  2020-01-10       Impact factor: 5.923

Review 9.  Recent Strategic Advances in CFTR Drug Discovery: An Overview.

Authors:  Marco Rusnati; Pasqualina D'Ursi; Nicoletta Pedemonte; Chiara Urbinati; Robert C Ford; Elena Cichero; Matteo Uggeri; Alessandro Orro; Paola Fossa
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

Review 10.  CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.

Authors:  Miquéias Lopes-Pacheco
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.